Serum vitamin D levels are lower in Australian children and adolescents with type 1 diabetes than in children without diabetes

Pediatric Diabetes

Volumn 14, Issue 1, 2013, Pages 31-41

  Greer, Ristan M ^a   Portelli, Sharon L ^a   Hung, Betsy Shin Min ^a   Cleghorn, Geoffrey J ^a   Mcmahon, Sarah K ^b   Batch, Jennifer A ^b   Conwell, Louise S ^a,b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Paediatrics; Type 1 diabetes; Vitamin D; Vitamin D receptor

Indexed keywords

CALCIFEDIOL; CALCITRIOL; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; AUSTRALIA; BLOOD SAMPLING; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE MARKER; FEMALE; FITZPATRICK SKIN CLASSIFICATION; GENOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LATITUDE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SELF REPORT; SINGLE NUCLEOTIDE POLYMORPHISM; SUNLIGHT; TROPIC CLIMATE; ULTRAVIOLET B RADIATION; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ADOLESCENT; AUSTRALIA; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; PARATHYROID HORMONE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RECEPTORS, CALCITRIOL; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84872943650     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2012.00890.x     Document Type: Article

References (46)

1. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol 2010: 10: 482-496.
2. Gysemans CA, Cardozo AK, Callewaert H et al. 1, 25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. Endocrinology 2005: 146: 1956-1964.
3. van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011: 91: 79-118.
4. Taverna MJ, Selam JL, Slama G. Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes. J Clin Endocrinol Metab 2005: 90: 4803-4808.
5. Taverna MJ, Sola A, Guyot-Argenton C et al. Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy. Diabetologia. 2002: 45: 436-442.
6. Guo SW, Magnuson VL, Schiller JJ, Wang X, Wu Y, Ghosh S. Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies. Am J Epidemiol 2006: 164: 711-724.
7. Ponsonby AL, Pezic A, Ellis J et al. Variation in associations between allelic variants of the vitamin D receptor gene and onset of type 1 diabetes mellitus by ambient winter ultraviolet radiation levels: a meta-regression analysis. Am J Epidemiol 2008: 168: 358-365.
8. Holick MF. Vitamin D: evolutionary, physiological and health perspectives. Curr Drug Targets 2011: 12: 4-18.
9. Mathieu C, Gysemans C, Giulietti A, Bouillon R. Vitamin D and diabetes. Diabetologia 2005: 48: 1247-1257.
10. Ponsonby AL, Lucas RM, van der Mei IA. UVR, vitamin D and three autoimmune diseases-multiple sclerosis, type 1 diabetes, rheumatoid arthritis. Photochem Photobiol 2005: 81: 1267-1275.
11. Grant WB. Epidemiology of disease risks in relation to vitamin D insufficiency. Prog Biophys Mol Biol 2006: 92: 65-79.
12. Hypponen E, Laara E, Reunanen A, Jarvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001: 358: 1500-1503.
13. Akerblom HK, Vaarala O, Hyoty H, Ilonen J, Knip M. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet 2002: 115: 18-29.
14. Norris JM. Can the sunshine vitamin shed light on type 1 diabetes? Lancet 2001: 358: 1476-1478.
15. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child 2008: 93: 512-517.
16. Baumgartl HJ, Standl E, Schmidt-Gayk H, Kolb HJ, Janka HU, Ziegler AG. Changes of vitamin D3 serum concentrations at the onset of immune-mediated type 1 (insulin-dependent) diabetes mellitus. Diabetes Res 1991: 16: 145-148.
17. Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004: 79: 362-371.
18. Pozzilli P, Manfrini S, Crino A et al. Low levels of 25-hydroxyvitamin D3 and 1, 25-dihydroxyvitamin D3 in patients with newly diagnosed type 1 diabetes. Horm Metab Res 2005: 37: 680-683.
19. San-Pedro JI, Bilbao JR, Perez de Nanclares G, Vitoria JC, Martul P, Castano L. Heterogeneity of vitamin D receptor gene association with celiac disease and type 1 diabetes mellitus. Autoimmunity 2005: 38: 439-444.
20. Ongagna JC, Pinget M, Belcourt A. Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes. Clin Biochem 2005: 38: 415-419.
21. Shih ST, Carter R, Sinclair C, Mihalopoulos C, Vos T. Economic evaluation of skin cancer prevention in Australia. Prev Med 2009: 49: 449-453.
22. Munns C, Zacharin MR, Rodda CP et al. Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. Med J Aust 2006: 185: 268-272.
23. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988: 124: 869-871.
24. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999: 69: 842-856.
25. Tajouri L, Ovcaric M, Curtain R et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet 2005: 19: 25-38.
26. UCLA: Academic Technology Consulting Services SCG. STATA data analysis examples. Robust regression.
27. Greer RM, Rogers MA, Bowling FG et al. Australian children and adolescents with type 1 diabetes have low vitamin D levels. Med J Aust 2007: 187: 59-60.
28. Littorin B, Blom P, Scholin A et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 2006: 49: 2847-2852.
29. Anonymous. Queensland Public Health Forum: Under the Queensland Sun. In: Kim lin MG, ed. Queensland Skin Cancer Prevention Strategic Plan 2008-2013. Queensland Health, Brisbane, 2008.
30. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia. 1999: 42: 51-54.
31. Bierschenk L, Alexander J, Wasserfall C, Haller M, Schatz D, Atkinson M. Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care 2009: 32: 1977-1979.
32. Huynh T, Greer RM, Nyunt O et al. The association between ketoacidosis and 25(OH)-vitamin D levels at presentation in children with type 1 diabetes mellitus. Pediatr Diabetes 2009: 10: 38-43.
33. Hewison M. Vitamin D and immune function: an overview. Proc Nutr Soc 2011: 1-12.
34. Aydin S, Aslan I, Yildiz I et al. Vitamin D levels in children with recurrent tonsillitis. Int J Pediatr Otorhinolaryngol 2011: 75: 364-367.
35. Esteitie R, Naclerio RM, Baroody FM. Vitamin D levels in children undergoing adenotonsillectomies. Int J Pediatr Otorhinolaryngol 2010: 74: 1075-1077.
36. Auwerx J, Dequeker J, Bouillon R, Geusens P, Nijs J. Mineral metabolism and bone mass at peripheral and axial skeleton in diabetes mellitus. Diabetes 1988: 37: 8-12.
37. Carnevale V, Romagnoli E, D'Erasmo E. Skeletal involvement in patients with diabetes mellitus. Diabetes Metab Res Rev 2004: 20: 196-204.
38. Mathiassen B, Nielsen S, Johansen JS et al. Long-term bone loss in insulin-dependent diabetic patients with microvascular complications. J Diabet Complications 1990: 4: 145-149.
39. Saggese G, Bertelloni S, Baroncelli GI, Federico G, Calisti L, Fusaro C. Bone demineralization and impaired mineral metabolism in insulin-dependent diabetes mellitus. A possible role of magnesium deficiency. Helv Paediatr Acta 1989: 43: 405-414.
40. De Schepper J, Smitz J, Rosseneu S, Bollen P, Louis O. Lumbar spine bone mineral density in diabetic children with recent onset. Horm Res 1998: 50: 193-196.
41. Al-Qadreh A, Voskaki I, Kassiou C, Athanasopoulou H, Sarafidou E, Bartsocas CS. Treatment of osteopenia in children with insulin-dependent diabetes mellitus: the effect of 1 alpha-hydroxyvitamin D3. Eur J Pediatr 1996: 155: 15-17.
42. Hamed EA, Abu Faddan NH, Adb Elhafeez HA, Sayed D. Parathormone - 25(OH)-vitamin D axis and bone status in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2011: 12: 536-546.
43. Simpson M, Brady H, Yin X et al. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 2011: 54: 2779-2788.
44. Casteels KM, Mathieu C, Waer M et al. Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1, 25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. Endocrinology 1998: 139: 95-102.
45. Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Prevention of autoimmune diabetes in NOD mice by 1, 25 dihydroxyvitamin D3. Diabetologia 1994: 37: 552-558.
46. Holick MF. Vitamin D: extraskeletal health. Endocrinol Metab Clin North Am 2010: 39: 381-400 table of contents.